Methotrexate Is a JAK/STAT Pathway Inhibitor.
The JAK/STAT pathway transduces signals from multiple cytokines and controls haematopoiesis, immunity and inflammation. In addition, pathological activation is seen in multiple malignancies including the myeloproliferative neoplasms (MPNs). Given this, drug development efforts have targeted the path...
Main Authors: | Sally Thomas, Katherine H Fisher, John A Snowden, Sarah J Danson, Stephen Brown, Martin P Zeidler |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4489434?pdf=render |
Similar Items
-
Advances in genome-wide RNAi cellular screens: a case study using the <it>Drosophila</it> JAK/STAT pathway
by: Fisher Katherine H, et al.
Published: (2012-09-01) -
Localised JAK/STAT pathway activation is required for Drosophila wing hinge development.
by: Kirsty Johnstone, et al.
Published: (2013-01-01) -
JAK/STAT Pathway Mutations in T-ALL, Including the STAT5B N642H Mutation, are Sensitive to JAK1/JAK3 Inhibitors
by: Inge Govaerts, et al.
Published: (2019-12-01) -
Suppression of Autoimmune Arthritis by Small Molecule Inhibitors of the JAK/STAT Pathway
by: Charles J. Malemud
Published: (2010-05-01) -
Protein Inhibitor of Activated STAT (PIAS) Negatively Regulates the JAK/STAT Pathway by Inhibiting STAT Phosphorylation and Translocation
by: Guo-Juan Niu, et al.
Published: (2018-10-01)